The frequency of KRAS mutation varies among the CRC subtypes (23% in CMS1, 38% in CMS2, 28% in CMS3, and 68% in CMS4) and this could explain the different behavior of mutated tumors (7). The gene discussed is KRAS; the disease is colorectal carcinoma.